MARATTO

article · PubMed

[Predictive factors of non-invasive ventilation failure in patients with severe acute exacerbation of chronic obs-tructive pulmonary disease. Multicenter study].

Abstract

BACKGROUND: Non invasive ventilation (NIV) has become an integral tool to assist patients with severe chronic obstructive pulmonary disease (COPD) exacerbation. However, the success of NIV in these patients remains relatively random and predictors of response are poorly known. AIM: To study the predictors of NIV failure in patients hospitalized for severe COPD exacerbation. METHODS: Comparative and retrospective study including patients hospitalized for severe COPD exacerbation and who received NIV. Our work studied the predictive factors of NIV failure. Failure of NIV is defined by transfer to intensive care unit (ICU) with use of invasive ventilation. RESULTS: Among the 268 patients hospitalized in the pulmonology department during the study period for COPD exacerbation, 68 (25.4 %) required the use of NIV. The average age was 60.8 ± 9.6 years. Sex ratio was 8.6. In multivariate analysis, cyanosis [Odds Ratio (OR) : 31.5; 95 % Confidence Interval (CI) : 4.5-221.9], heart rate ≥ 110 beats/min (OR : 10.1, 95 % CI : 1.9-52.9), signs of respiratory encephalopathy (OR : 6.6, 95 % CI : 1.4-32.1) and poor tolerance to NIV (OR : 5.9 % CI : 1.1-25.8) were associated with the ICU transfer. CONCLUSION: Presence at admission of cyanosis, tachycardia, signs of respiratory encephalopathy and poor tolerance to NIV are predictive factors for NIV failure in patients with severe COPD exacerbation.

Research topics

  • Respiratory Support and Mechanisms
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Nosocomial Infections in ICU

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.